RxDoctor Payments Data

Shelley Blackburn, MD

Family Medicine · Columbus, OHNPI 1750327565

Payments from drug & device makers

$9,834in general payments, 2019–2025

Across 628 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Viiv Healthcare Company$1K
  • AstraZeneca$710
  • Amgen$708
  • Gilead$523
  • Novo Nordisk$418
  • plus $5K from 53 others

What the payments were for

  • Food & beverage$9,74399%
  • Education$911%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)134$1,474
Viiv Healthcare Company57$1,158
AstraZeneca45$710
Amgen(2 entities)43$708
Gilead26$523
Novo Nordisk29$418
Boehringer Ingelheim20$353
Pfizer19$352
Lilly USA, LLC20$338
Merck24$285
Johnson & Johnson(2 entities)23$283
GSK21$250
Astellas Pharma US Inc14$247
Takeda Pharmaceuticals U.S.A., Inc.15$245
Axsome Therapeutics, Inc.11$231
Bayer8$168
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC10$158
Otsuka America Pharmaceutical, Inc.6$125
Novartis7$110
Supernus Pharmaceuticals, Inc.6$107
Corium, LLC6$104
E.r. Squibb & Sons, L.L.C.6$101
Abbott6$100
Kowa Pharmaceuticals America, Inc.6$88
Lundbeck LLC5$87
Esperion Therapeutics, Inc.5$77
Exact Sciences4$77
Janssen Products, LP1$69
Antares Pharma, Inc.4$64
Biohaven Pharmaceutical Holding Company Ltd.3$62
Theratechnologies Inc.2$51
Tolmar, Inc.3$51
Rhodes Pharmaceuticals L.p.3$49
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$48
Amarin Pharma, Inc.3$46
Mayne Pharma Commercial LLC2$41
Sanofi-aventis U.S. LLC3$41
Phathom Pharmaceuticals, Inc.2$40
Circassia Inc.2$32
Biohaven Pharmaceuticals, Inc.2$28
Arbor Pharmaceuticals, Inc.2$26
Optinose US, Inc.1$24
Dexcom, Inc.1$24
Lucid Diagnostics Inc.1$23
Cook Medical LLC1$22
Vertex1$19
Genentech USA, Inc.1$19
Aytu Biopharma, Inc.1$18
Nestle Healthcare Nutrition Inc.1$18
Shield Therapeutics Inc1$17
Amneal Pharmaceuticals LLC1$15
Idorsia Pharmaceuticals US Inc1$15
Bausch Health US, LLC1$15
Napo Pharmaceuticals Inc1$15
Shire North American Group Inc1$14
Vanda Pharmaceuticals Inc.1$13
Tris Pharma Inc1$12
Adlon Therapeutics L.p.1$12
Organon1$10

How this compares

$9,834 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$99,791
Medicare patients
301
Services billed
1,256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide82$101,807
JardianceEmpagliflozin48$40,394
EliquisApixaban47$40,147
DovatoDolutegravir Sodium/Lamivudine14$36,855
JanuviaSitagliptin Phosphate38$31,014
MounjaroTirzepatide23$22,206
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$19,054
Tresiba Flextouch U-100Insulin Degludec21$17,854
FarxigaDapagliflozin Propanediol24$16,796
MyrbetriqMirabegron18$8,437
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,614
TrintellixVortioxetine Hydrobromide13$6,474
Advair HfaFluticasone Propion/Salmeterol11$4,587
PaxlovidNirmatrelvir/Ritonavir22$4,117
Levothyroxine Sodium316$2,638

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$418$101,80782 claims
PfizerEliquis, Paxlovid$352$44,26469 claims
Boehringer IngelheimJardiance$353$40,39448 claims
Viiv Healthcare CompanyDovato$1,158$36,85514 claims
MerckJanuvia$285$31,01438 claims
AstraZenecaFarxiga, Breztri Aerosphere$710$24,41036 claims
Lilly USA, LLCMounjaro$338$22,20623 claims
GSKTrelegy Ellipta$250$19,05427 claims
Astellas Pharma US IncMyrbetriq$247$8,43718 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$245$6,47413 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$2,638316 claims
AbbVieSynthroid$1,474$1,38436 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →